Antibody-Drug Conjugates (ADCs)

Antibody-Drug Conjugates (ADCs)

Catalog Product Name CAS Number
BADC-01597 Ladiratuzumab vedotin
Ladiratuzumab vedotin is an antibody-drug conjugate consisting of a humanized anti-LIV-1 IgG1 conjugated with monomethyl auristatin E (MMAE). Ladiratuzumab vedotin has the potential for the treatment ... Inquiry
BADC-01598 Anetumab-MMAE
Anetumab-MMAE is an antibody-drug conjugate consisting of an anti-MSLN monoclonal antibody and monomethyl auristatin E (MMAE). MMAE is an antimitotic agent that inhibits tubulin polymerization. Inquiry
BADC-01599 Anetumab ravtansine 1375258-01-7
Anetumab ravtansine is an antibody-drug conjugate consisting of an anti-MSLN monoclonal antibody and the maytansinoid tubulin inhibitor DM4. Anetumab ravtansine has the potential for the treatment of ... Inquiry
BADC-01600 Sirtratumab vedotin 1824663-83-3
Sirtratumab vedotin is an antibody-drug conjugate consisting of a SLITRK6-specific human antibody conjugated to MMAE via a protease-cleavable linker. Sirtratumab vedotin has the potential for the trea... Inquiry
BADC-01601 Tusamitamab ravtansine 2254086-60-5
Tusamitamab ravtansine is an antibody-drug conjugate consisting of an anti-carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) antibody conjugated to the potent cytotoxic antitubulin D... Inquiry
BADC-01602 Trastuzumab deruxtecan 1826843-81-5
Trastuzumab deruxtecan is an antibody-drug conjugate consisting of humanized anti-HER2 antibody and a topoisomerase I inhibitor payload. Trastuzumab deruxtecan has been used in the research of HER2 ex... Inquiry
BADC-01603 Sacituzumab govitecan 1491917-83-9
Sacituzumab govitecan is an antibody-drug conjugate with an SN-38 payload targeting trophoblast cell-surface antigen 2, an epithelial antigen expressed in breast cancer. Inquiry
BADC-01604 Disitamab vedotin 2136633-23-1
Disitamab vedotin is an antibody-drug conjugate consisting of the novel humanized anti-HER2 antibody (hertuzumab) conjugated to monomethyl auristatin E (MMAE) via a cleavable linker. Disitamab vedotin... Inquiry
BADC-01605 Telisotuzumab vedotin 1714088-51-3
Telisotuzumab vedotin is a c-Met-targeted antibody and MMAE drug conjugate. Telisotuzumab vedotin has the potential for advanced non-small cell lung cancer treatment. Inquiry
BADC-01606 Polatuzumab vedotin 1313206-42-6
Polatuzumab vedotin is an antibody-drug conjugate targeting CD79b. Polatuzumab vedotin has been approved for the treatment of patients with relapsed/refractory large B-cell lymphoma (LBCL). Inquiry
BADC-01607 Belantamab mafodotin 2050232-20-5
Belantamab mafodotin is an antibody-drug conjugate consisting of an antibody targeting B-cell maturation antigen (BCMA) conjugated to the microtubule inhibitor monomethyl auristatin F (MMAF). Belantam... Inquiry
BADC-01608 Loncastuximab tesirine 1879918-31-6
Loncastuximab tesirine is an anti-CD19 antibody-drug conjugate. Loncastuximab tesirine has been used in the research of relapsed or refractory diffuse large B-cell lymphoma (DLBCL). Inquiry
BADC-01609 Patritumab deruxtecan 2227102-46-5
Patritumab deruxtecan is an antibody-drug conjugate consisting of a human anti-HER3 monoclonal antibody conjugated to a topoisomerase I inhibitor payload via a stable tetrapeptide-based cleavable link... Inquiry
BADC-01610 Tisotumab vedotin 1418731-10-8
Tisotumab vedotin is an antibody-drug conjugate comprising a fully human monoclonal antibody specific for tissue factor (TF-011) conjugated to monomethyl auristatin E (MMAE). Tisotumab vedotin has bee... Inquiry
BADC-01611 Farletuzumab ecteribulin 2407465-18-1
Farletuzumab ecteribulin is an antibody-drug conjugate consisting of the humanized antifolate receptor-alpha (FRα) monoclonal antibody conjugated to eribulin by a cathepsin B-cleavable linker. Inquiry
BADC-01612 Moxetumomab pasudotox 1020748-57-5
Moxetumomab pasudotox is a recombinant immunotoxin composed of the Fv fragment of an anti-CD22 monoclonal antibody fused to a 38-kDa fragment of Pseudomonas exotoxin A, called PE38. Moxetumomab pasudo... Inquiry
BADC-01613 Zilovertamab vedotin
Zilovertamab vedotin is a receptor tyrosine kinase-like orphan receptor 1 (ROR1) targeting antibody-drug conjugate consisting of zilovertamab, a proteolytically cleavable linker, and the antimicrotubu... Inquiry
BADC-01614 Glembatumumab vedotin 1182215-65-1
Glembatumumab vedotin is an antibody-drug conjugate consisting of a fully human IgG2 monoclonal antibody (CR011) against gpNMB conjugated to the microtubule inhibitor, monomethyl auristatin E (MMAE). ... Inquiry
BADC-01615 Trastuzumab duocarmazine 1642152-40-6
Trastuzumab duocarmazine is a HER2-targeting antibody-drug conjugate comprised of trastuzumab bound to a linker drug containing duocarmycin. Trastuzumab duocarmazine has been used in the research of H... Inquiry
BADC-01616 Cantuzumab ravtansine 868747-45-9
Cantuzumab ravtansine is an antibody-drug conjugate comprised of a humanized monoclonal antibody cantuzumab (huC242) linked to a cytotoxic agent, ravtansine (DM4). Inquiry
* Only for research. Not suitable for any diagnostic or therapeutic use.
Inquiry Basket